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Introduction
Firmness and closeness of the cervix are nec-
essary throughout the whole pregnancy except for
the few last weeks for the maintenance of pregnan-
cy(1); whereas the improvement of natural childbirth
depends on the ripening of the cervix(2). The most
common method of evaluation of the ripening of
the cervix was firstly recommended by Bishop in
1964 as the Bishop Scoring method based on scor-
ing including 5 components (dilation, effacement,
condition and strength of the cervix and display sta-
tion of the organ)(3). Currently, the Bishop score
evaluation method is widely used as the most accu-
rate and valuable of evaluating ripening of the
cervix(4). In other words, the higher the Bishop score
is, the more ready the cervix will be and the proba-
bility of vaginal delivery increases and the proba-
bility of caesarean section decreases(5, 9). The results
obtained from the studies indicate that low bishop
score brings pain, long delivery, and the risk of
increasing the prevalence of C-sections(5) and its
side effects are complications of anesthesia, bleed-
ing, infection and repeated C-sections(6).
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ABSTRACT
Introduction: Ripening of the cervix and uterine contractions are two basic factors of a successful delivery. Lack of ripening of
the cervix is considered to be one of the problems of delivery. Thus, the present research was designed to determine the effect of oral
evening primrose capsules on the ripening of cervix in nulliparous women. 
Materials and methods: This research has been conducted with the triple-blind randomized trial method on 80 nulliparous
women in the 40th week of pregnancy (6th day + 40 weeks) visiting the prenatal clinic Prenatal clinic Shahid Akbarabadi educatio-
nal and medical center of Iran University of Medical Sciences in 2015. Samples were divided into two equal groups of medicine and
placebo with the randomized allocation method. Each of the participants took a bottle containing 14 1000mg oral evening primrose
capsules (2 capsules per day, each 12 twelve hours for a week) or the placebo containing 14 1000mg oral capsules of paraffin in
similar bottles. Data collecting tools include: demographic specifications questionnaire and the form of the records of the examina-
tions. Data was analyzed through statistical tests and SPSS software version 16 using descriptive inferential statistic. 
Findings: Similarity of the two groups in terms of individual specifications and Bishop Score before the intervention were
reviewed in the two groups and no significant statistical difference was seen between the two groups. The mean of the Bishop score
for those who had taken 10 or more capsules after the intervention did not show a statistically significant difference (p=0.110).
Conclusion: Consumption of evening primrose did not show a considerable improvement in the score. It is recommended to do
more comparative studies in this field in later weeks of pregnancy due to the conflicts of the studies. 
Key words: Ripening of the Cervix, Evening primrose, Pregnancy.
Length of the pain of delivery is also followed
by complications such as mother's tiredness,
increase of fear and anxiety during the current and
the next delivery and probability of increasing
infection in the mother and the newborn during and
after the delivery(7). In addition, length of delivery
and the intensity of its pain are among the basic
causes of mothers' fear of delivery and their tenden-
cy towards c-section operations(8). Beginning of
delivery with an undesirable cervix is also an
important factor for predicting the condition of
newborns who require hospitalization after being
born(9). Bishop scores that are lower than or equal to
4 which are assigned to the cervix are considered
undesirable and might be considered as the indica-
tions of preparation of the cervix(10).
Cervix preparation methods are divided into
two methods: medical methods such as E1 and E2
prostaglandin and mechanical methods such as
Foley catheter. The most common method of cervix
preparation is using different types of
prostaglandin. However, it also has numerous side
effects including Tachysystole, Aaspiration,
Hypertonicity and Hygroscopic along with undesir-
able impacts on the heartbeat of the fetus, fever,
nausea, vomiting, diarrhea and neonatal adverse
consequences. That is why these products shall only
be used in the delivery room and when it is possible
to monitor the activity of the uterus and the fetal
heart rate(10). Application of mechanical methods
such as Foley catheter also requires hospitalizing
and monitoring pregnant women and is followed by
increase of c-sections, uterine infections, and
unnecessary examinations at the time of hospital-
ization in the hospital(10, 11).
In addition to using various medical methods
to make the cervix ready, there are also some tradi-
tional methods such as using various forms of med-
icinal plants(12) n emphasizes on using herbal medi-
cines due to severe side effects of the chemical
ones(13). Among herbal medicines, primrose oil, cas-
tor oil and red raspberry leaf are among herbal
medicines which are used in order to stimulate and
accelerate delivery and prepare the cervix(14). A
study in this field was done by Gibson and
McFarlane in 1991 with the purpose of document-
ing usage of herbal products to prepare, stimulate
and reinforce labor by the midwives.
The study showed that they had used castor oil
for 93%, blue cohosh for 64%, red raspberry leaf
for 60%, Evening primrose oil for 60% and black
cohosh for 45%. Thus, they stated that the most
effective method is using Evening primrose oil for
softening the cervix and that the most effective
application of castor oil is for labor stimulation.
Primrose is a wild two-year plant with yellow flow-
ers that grows in North America and some parts of
Europe. Evening primrose oil (EPO) is extracted
from the seeds of this plant including 50-70% of
Linoleic acid, 7-10% of Gamma Linoleic acid and a
small rate of oleic, palmitic and stearic acids(15)
(Graph 1).:
Two necessary fatty acids Linoleic acid, and
Gamma Linoleic facilitate E2 prostaglandin synthe-
sis(16). Preparation of the cervix is related to some
medium factors and E2 and F2α prostaglandin
seem to be the ultimate medium in this process(10).
Using EPO is useful for different types of disorders
including Atopic Dermatitis, Rheumatoid arthritis,
Diabetic neuropathy, multiple sclerosis, many types
of cancer, Raynaud’s phenomenon, Ulcerative coli-
tis, Preeclampsia, premenstrual syndrome, hot
flashes during the menopause, cysts and pain in the
breasts, Sjogren’s syndrome, Schizophrenia and
hyperactivity(17, 18, 19).
According to the opinion of the National
Center for Complementary and Alternative
Medicine, primrose is generally tolerated well by
individuals but also causes a mild upset stomach
and headache(22). Thus, since EPO is generally toler-
ated well(20), there is no limit for using it during the
pregnancy(19) because it has no effect on the safety
of the fetuses monitored by the biophysical profile
test and stress-free test(21) and its consumption as an
oral capsule is easy and does not require hospital-
ization and constantly monitoring the fetus(22). Iran
is one of the most important areas in terms of prop-
er weather, and cultivation of evening primrose(23).
1274 Fereshteh Jahdi, Mahnazalati Kalati et Al
Graph 1: Research Method Diagram.
Given that finding a non-invasive, non-phar-
macological method with less side effects than that
of the common mechanical and pharmacological
methods in the preparation of cervix, according to
the studies, will lead to the reduction of fatal and
motherhood complications and reduction of the
time spent by the pregnant woman, financial
expenses imposed on a person and health system of
the society, and using primrose capsule is a non-
invasive and non-pharmacological method, it is rec-
ommended as the non-invasive non-pharmacologi-
cal method with minimum complications. Also,
given that very few studies have been done in this
regard in the world, and especially no documents
have been recorded yet in the field above in Iran,
researchers attempted to conduct a research with
the purpose of determining the effect of this medici-
nal plant on the ripening and softening of the cervix
so that if the research hypotheses are confirmed, the
researchers will be able to recommend this natural,
non-invasive method for an easier labor with less
risks. 
Materials and methods
This research has been conducted with the
triple-blind randomized trial method with two
groups of medicine and placebo from August to
December of 2015 after being authorized by the
Ethics Committee of Iran University of Medical
Sciences and registering with the number
(IRCT201507022248N17) in IRCT in Prenatal clin-
ic Shahid Akbarabadi educational and medical cen-
ter by getting the permission of the beneficiary ref-
erences. Research units included 90 nulliparous
women visiting the prenatal infirmary of Prenatal
clinic Shahid Akbarabadi educational and medical
center.
Criteria of entering the study include: healthy
pregnant women originally from Iran who are not at
risk that much (lack of surgical diseases or known
surgeries or pregnancy complications such as para-
noia, placental abruption, preeclampsia and lack of
fetal problems) and pregnancy age (40 week) to
(6th day + 40 weeks) based on the latest day of
period and sonogram of the first three month, live
fetus, cephalic fetal presentation, natural pattern of
fetal heart rate, lack of uterine contractions, Bishop
score of less than 4, healthy membrane, mother's
height of more than 150cm, lack of drug abuse, nat-
ural modified biophysical profile testing at the time
of entering the study, having a sonogram in terms of
placental grading, an estimated weight of fetus
between 2500 and 4000 grams based on a manual
examination of the abdomen or sonogram, avoiding
using enema, no intercourse, consumption of laxa-
tives, herbal and chemical medicines or traditional
methods for the beginning of the pain of labor, lack
of vaginal examination from hours before the
beginning of the study to the end. 
Criteria of exiting the study: consuming less
than two capsules per day, c-section due to any rea-
son and probable side effects related to medicine
such as headache, nausea, diarrhea and other items.
Given the sample volume, by using an available
similar research in the field of effect of EPO cap-
sule on the Bishop score by considering the confi-
dence level of 95% and a test power of 80% and by
assuming that the rate of impact of intervention
(impact of EPO capsule on the Bishop score) in
comparison with the control group is at least d=1,
after placing the values in the formula, each group
was estimated to include 40 persons. By calculating
the probability of the elimination of the components
of the sample, ultimately 45 persons were put in
each group that makes a total of 90 persons. 
The sampling method was as such that firstly,
90 women with the criteria of entering the study
who agreed to participate in the study, after getting
a written consent, were cautiously put in one of the
two groups of using the primrose capsule or the
placebo; in such way that the names of each of the
two groups were written as codes A and B on paper
and were put inside separate envelops. The first
sample that entered the study picked out one of the
envelops and the next person went to the other
group and the same was done for the third person
and the fourth person went to the second group so
that all of the individuals in the sample volume
would enter one of the two groups of the study
either consuming EPO capsules (45 persons) or
placebo (45 persons). 
The tools use in this research include a two-
form questionnaire and a sheet of the records of the
hours of drug consumption, sheet of recording and
reviewing the unwanted complications of the
Ministry of Health and Medical Education of Iran
and department of food and drug. In order to deter-
mine the validity of the questionnaire, appearance
and content validity method was used; in such way
that firstly the valid articles were studied, the data
gathering tools were selected and then in order for
the ultimate review, they were given to 10 of the
faculty members of the department of nursing and
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midwifery of Iran University of Medical Sciences.
Ultimately, the questionnaire was arranged and
used. For the Bishop score to be reliable, firstly 10
examinations were done by the researcher and they
were controlled by another fellow midwife at the
same rank and its correlation was more than 0.99
and that is how its reliability was confirmed. All of
the capsules had the same shape and color and were
coded A and B by the pharmacist in similar pack-
ages.
The research samples and groups and statisti-
cal analyzers did not know what the capsules con-
tained; thus the present research was a triple-blind
one. Demographic specification questionnaires and
record of preliminary examinations included the
mother's vital signs, conditions of fatal heart rate,
uterine contradictions, and cervix Bishop score and
were filled out in the infirmary. Then each of the
participants took a bottle containing 14 1000mg
oral evening primrose capsules (2 capsules per day,
each 12 twelve hours for a week) or the placebo
containing 14 1000mg oral capsules of paraffin in
similar bottles A o B. The safe dose of EPO,
according to the studies, is at most 2-16 500mg
capsules per day(17). Also, dose of 3g EPO is 3
capsules per day (2*500gm capsules or 1*1000mg
capsules)(24). About the instruction of consuming the
capsules, the required information was given to the
studied individuals. Throughout the research, the
researcher kept in touch with the participants by
phone in order to get information about the samples
or the probability of the occurrence of complica-
tions related to the consumption of capsules. After
the capsules are all taken, or in case of presence of
warning symptoms including a runny nose, bleed-
ing, reduction of fetal movement, severe abdominal
pain, the pregnant women shall visit a hospital. And
the researcher went to the hospital and recorded all
of the information and determined examinations in
the questionnaire and the form of examinations. At
the time of the visit, the examinations were done in
order to calculate the Bishop score and they were
recorded in the form of examinations. It is neces-
sary to mention that the rate of elimination of the
sample was 10% in the present research. During the
process of the research, out of the 90 samples, ulti-
mately, 5 persons were eliminated from the EPO
capsule group (40 persons) and 5 persons were
eliminated from the placebo group; in such way
that out of the 6 persons eliminated in the allocation
stage in the placebo group, one person was elimi-
nated due to the increase of blood pressure (blood
pressure during pregnancy) and a person for being
hospitalized in other centers, and in the medicine
group one person was eliminated due to lack of ten-
dency towards continuing to cooperate and three
persons were eliminated for being hospitalized in
other centers. Also, in the Follow Up stage, four
persons were eliminated for c-section, one person
in the medicine group was eliminated due to
improper bit to bit and three persons in the placebo
group were eliminated due to late drop of heart rate
and bleeding. And ultimately, in total, 80 persons
participated in the research (graph 1). At the end,
after analyzing the information and getting the final
results, type of each medicine and the pharmacist
was asked about the code related to it and finally
the results were discussed for the last time. Data
analysis was done in two stages. In the first stage,
in order to describe demographic specifications, the
descriptive statistical tests including relative and
absolute frequency of mean and standard deviations
were used and in the next stage, in order to compare
the means, the accurate Fisher test, Chi-square and
independent statistical T-tests were used.
Ultimately, in order to analyze the data, SPSS soft-
ware ver.16 was used. 
Findings
The age average in the medicine and placebo
group was respectively 24.00 and 24.85 years. 57.5
percent of the researched units in the medicine
group and 60 percent in the placebo unit had gradu-
ated high school and had a diploma. All of the
mothers in the placebo group and 95% of those in
the medicine group were housewives. The average
body mass index has been respectively 23.46 and
23.35 in the medicine and placebo group.
According to the results of this study, the two
groups have been similar in terms of age average of
the mother and her husband (independent statistical
t-test), mother's level of education (chi-square test),
fathers' level of education and occupation of the
mother and the father (accurate Fisher test), moth-
er's body mass index (independent t-test) and statis-
tical tests did not show a significant statistical dif-
ference between the groups (P>0.05). Also, the two
groups did not have a significant statistical different
in terms of pregnancy based on the first day of the
latest period or the sonogram of the first three
months (table 1).
The statistical independent t-test indicated that
the mean of the Bishop score in the two reviewed
groups before the intervention does not have a sig-
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nificant statistical difference compared to after it.
The average of the Bishop score in the medicine
and placebo groups, before the intervention, was
respectively equal to 1.05±1.17 AND 1.25±1.08.
In addition, the findings showed that the
majority of the studied units did not have cervix
ripening in the medicine group (90%) and in the
placebo group (80%) (P=0.110). Standard deviation
of the average of the Bishop score has obtained to
be equal to 3.60±1.75 and 4.35±2.34 in the medi-
cine and placebo groups, respectively, after the
intervention. The results of the independent t-test
also showed lack of a significant statistical differ-
ence between the two groups (P=0.431) (Table 4). 
According to table 2, the number of individu-
als who took 10 or more than 10 capsules, is 46.2%
in the medicine group and 42.5% in the placebo
group and 44.3% in total. And only 28.2% and 25%
in the placebo group took all of the 14 capsules and
also only 46.2% in the medicine group and 42.5%
in the placebo group took the capsules for 5 days
and more (table 3). 
Discussion
The research findings in the present study
indicated that taking the one EPO capsule two
times a day for a week does not have a considerable
effect on the Bishop score.
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Group
Individual specifications Group 1 Group 2 Test results
Mother's age 24.00±4.01 24.85±4.22
t=0.923
df=78
P-value = 0.359
Body mass index 23.46±3.71 23.35±3.53
t=0.135
df=78
P-value = 0.893
Spouse’s age 28.30±4.71 28.77±4.61
t=0.456
df=78
P-value = 0.650
Mother’s level of
education
Elementary and gui-
dance school 11(27.5%) 11(27.5%)
χ^2=0.112/0  df=2
p-value = 0.945High school and
diploma 23(5.5%) 24(60.0%)
University 6(15.0%) 5(12.5%)
Mother's occupa-
tion
status
Housewife 38(95.0%) 40(100.0%)
p-value=0.494
(0/5%)2 (0/0%)0
Spouse's level of
education
Illiterate 1(25%) 2(5.0%)
p-value=0.893
Elementary and gui-
dance school 16(40.0%) 16(40.0%)
High school and
diploma 17(42.5%) 18(45.0%)
University 6(15.0%) 4(10.0%)
Spouse's occupation
status
Employee 6(15.0%) 4(10.0%)
χ^2=0.459 df=2
p-value=0.795Worker 14(35.0%) 15(37.5%)
free 20(50.0%) 21(52.5%)
Table 1: Distribution of frequency of individual specifi-
cations of the researched units.
*Independent t-test
**Chi-square test
Group
Variable Medicine Placebo Total
Capsule 
5 >
Number 8 6 14
Percentage 20.50% 15.00% 17.70%
(5, 9)
Number 13 17 30
Percentage 33.30% 42.50% 38.00%
(10, 13)
Number 7 7 14
Percentage 18% 17.50% 17.70%
14
Number 11 10 21
Percentage 28.20% 25.00% 26.60%
Total 
Number 39 40 79
Percentage 100.00% 100.00% 100.00%
Table 2: Distribution of absolute and relative frequency
of the studied units based on the number of the consu-
med medicines.
Group
Interval
Medicine Placebo
Frequency Percentage Frequency Percentage 
Less than 3 days 10 25.6 9 22.5
3 to 5 days 11 28.2 14 35
5 days and more 18 46.2 17 42.5
Total 39 100 40 100
Standard deviation ±
mean 4.39±1.98 4.45±1.84
Results of the indepen-
dent t-test
t=0.122
df=77
p-value=0.903
Table 3: Distribution of absolute and relative frequency
of the studied units based on the duration of consump-
tion of the medicine till the beginning of labor.
Bishop Score Evening primrose Placebo
Group Mean and standarddeviation
Mean and standard
deviation Statistic
Before intervention 1.05±1.17 1.25±1.08
t=0.792
df=78
p-value=0.431
After intervention 3.60±1.75 4.35±2.34
t=1.619
df=72.12
p-value=0.11
Table 4: Comparing the mean of the Bishop score before
and after intervention in both medicine and placebo
groups.
In Dow and Johnson’s study (1999), with the
title review of the impact of primrose on the dura-
tion of pregnancy and consequences of pregnancy
on 54 women who were in the 37th week of their
pregnancy using 500mg EPO 3 times a day for the
first week and then two capsules per day until the
beginning of laber and 54 women who did not
receive a medicine in the control group, was indica-
tive of lack of a significant difference in terms of
age, Apgar score and days of pregnancy (P>0.05).
This study is compatible with the present study in
terms of lack of medicine's effect on other results of
pregnancy and labor; whereas the results of the
study of Ty-Torredes (2006).
This study was done in order to review the
impact of edible EPO on the Bishop score and
length of cervix during the pregnancy on 71 preg-
nant women in two groups containing 38 persons.
In the test group, the members took one EPO cap-
sule three times a day for a week and 33 persons
were in the placebo group. A considerable improve-
ment was seen in the Bishop score in the group
consuming the primrose capsule compared to the
group consuming the placebo (P=0.0001). Also, a
considerable reduction was seen in the length of the
cervix by the transvaginal ultrasound in the medi-
cine and placebo groups (p=0.001).
The results of this study do not comply with
the present study. One of the probable causes of this
difference is that in Ty-Torredes’s study, consump-
tion of medicine has began in the 39th week by the
research units; whereas the present research has
been conducted in the 40th week and the probabili-
ty of occurrence of the signs of labor before the
capsules finish is more in the 40th week compared to
previous weeks; in such way that only 28.2% in the
medicine group and 25% in the placebo group have
consumed the capsules completely. And also only
less than half of the research units consumed the
capsules for five days and more.
In fact, the beginning of the consumption of
the capsules in the later weeks increases the proba-
bility of a more complete consumption of capsules.
Thus, consumption of a different number of cap-
sules in the present research can be the reason for
which the research hypotheses are rejected. On the
other hand, ripening of the cervix occurs gradually
a few weeks before the beginning of labor and it
seems that the effective factors on this ripening
shall be reviewed during these weeks(25). As it has
been mentioned in the study of Dow and Johnson,
application of EPO few weeks before labor might
have a different effect on the results of pregnancy
and around labor. In another study done by Vahdat,
et al. in 2015 was done with the purpose of deter-
mining the effect of EPO on the dilation and ripen-
ing of the cervix before the Hysteroscopy opera-
tion. 28 women received EPO gel and 22 women
received placebo 6-8 hourse before the
Hysteroscopy operation in posterior vaginal fornix.
Total time of the dilation of cervix among individu-
als who received EPO was less than that of those
who had received placebo (p=0.003) and came to
the conclusion that primrose affects the ripening of
the cervix before the Hysteroscopy operation and
has no serious side effect.
Although this study has been done before
pregnancy for the ripening of cervix; but it has
showed the effect of EPO capsule on the ripening
of the cervix before the Hysteroscopy operation. It
is probable that the cause of incompatibility of this
study with the present study is using the gel in the
posterior vaginal fornix and different tools such as
different dilators for opening the cervix. For elimi-
nating these conflicts and finding out the certain
effect of evening primrose on the ripening of the
cervix, it is required to do various studies with a
strong methodology(26-27).
Conclusion
The results of the present study did not a sig-
nificant statistical difference in the effect of the
consumption of EPO on the preparation of the
cervix, therefore it is recommended to do more
studies in the later weeks of pregnancy and a higher
sample volume due to the conflicts of the studies. 
Limitations of the research
• Lack of an accurate and on time consump-
tion of the medicine by the participants: by inform-
ing the participants and repeatedly calling them so
that this would be prevented. 
• Simultaneous consumption of another medi-
cine by the participants of which the researcher
does not have information: by giving information to
the participants in the research this could be pre-
vented. 
• Visiting other centers for the labor by the
participants: by making the participants informed
about it, the occurrence of it can be prevented to
some extent; but due to the long distance of the
paths and presence of traffic, it was not controllable
completely. 
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